 |
|
|
 |
|
Borderline Personality Disorder: Course, Outcomes,
Interventions
Saturday, March 24, 2007
Ann Arbor, MI
|
|
Conference Sponsors |
The National Education Alliance for
Borderline Personality Disorder
in partnership with NARSAD
University of Michigan Department of Psychiatry
University of Michigan Depression Center
Wayne State University Department of Psychology
Michigan State University Department of Psychiatry
Washtenaw County Community Support and Treatment Services
Livingston County Community Mental Health
NAMI of Washtenaw |
|
Statement of need |
Borderline Personality disorder (BPD) is a
severe and generally chronic disorder and people who suffer
from it are underserved. Friends and families are often
bewildered and do not know how to help. Treatment programs
for those with BPD need to be more readily available.
Families need access to programs such as those already
developed for several other mental illnesses. BPD presents
patients, their families, clinicians, and researchers with
multiple challenges.
|
|
Purpose |
The complex challenges associated with BPD will be
addressed in order to inform mental health professionals,
families and consumers of the most current diagnostic and
treatment options available, and other issues of current
interest to those affected by this disorder. |
|
Audience |
The
Conference is for physicians, psychiatrists, psychologists,
social workers, family therapists, counselors, nurses,
emergency room personnel, law enforcement personnel and
agencies, educators, family members, friends, and consumers. |
|
Course description |
BPD presents clinicians and researchers,
patients and their families with multiple challenges. This
one-day meeting will provide a forum for professionals,
family members, and consumers to better understand this
complex disorder from various perspectives This conference
on borderline personality disorder will provide information
about the disorder and related topics
| ▪ |
Overview |
| ▪ |
Course of BPD |
| ▪ |
Biopsychology of BPD |
| ▪ |
Diagnostic issues |
| ▪ |
Suicidality |
| ▪ |
Parasuicidality |
| ▪ |
Family and consumer perspectives |
| ▪ |
Family research |
| ▪ |
Psychopharmacology |
| ▪ |
Transference-focused therapy |
| ▪ |
Mentalization Based Psychotherapy |
| ▪ |
Dialectical behavior therapy |
| |
|
|
|
Conference Objectives |
This conference on borderline
personality disorder will address the following objectives
and at the end of the conference, attendees will be better
able to identify, specify, and describe:
| ▪ |
The overall course and outcome of BPD (It is not as dire as
originally thought) |
| ▪ |
The role that emotion dysregulation plays in BPD.
|
| ▪ |
The role of parasuicide and suicidality plays in BPD
|
| ▪ |
How to assess and intervene in suicidality and parasuicidal
thinking in BPD |
| ▪ |
The difference types of evidenced based
treatments that are currently being applied to BPD |
| ▪ |
including Dialectical
Behavior Therapy, Mentalization Based Therapy, and
Transference-Focused Psychotherapy |
| ▪ |
The role and limits of pharmacotherapy in BPD
|
| ▪ |
Support for family and consumers with BPD |
|
|
|
|
Conference Program
with Video Presentations
|
| Welcome &
Opening Remarks |
Perry D. Hoffman, PhD
President, National Education Alliance for Borderline
Personality Disorder
Kenneth R. Silk, MD
Professor, Director, Personality Disorders Program
Department of Psychiatry,
University of Michigan Health System
Michelle Riba, MS, MD
Professor and Associate Chair, Dept. of Psychiatry,
University of Michigan
|
| Overview of
BPD: The Clinical Presentation and Long-term Course |
Mary C. Zanarini, EdD
Director, Laboratory for the Study of Adult Development
McLean Hospital, Belmont, Massachusetts
Associate Professor of Psychology,
Department of Psychiatry
Harvard Medical School, Boston, Massachusetts |
|
|
Mary C. Zanarini, EdD, is Director of the Laboratory for
the Study of Adult Development at McLean Hospital in
Belmont, Massachusetts, and Associate Professor of
Psychology in the Department of Psychiatry at Harvard
Medical School. Dr. Zanarini earned her undergraduate and
doctoral degrees at Harvard College, later completing a
clinical and research fellowship in Psychology in the
Psychosocial Research Program at McLean Hospital.
Dr. Zanarini is Chair of the NIMH Workgroup for the
Development of Guidelines for Treatment Research on BPD and
Chair of the World Federation of Societies of Biological
Psychiatry Task Force on Personality Disorders. An active
researcher, she is currently Principal or Co-Principal
Investigator on three NIMH-funded studies: two investigating
the long-term course of BPD and one investigating the
genetics of BPD. Through her research, she has developed
measures to assess various aspects of borderline
psychopathology such as the Diagnostic Interview for
Personality Disorders and the Zanarini Rating Scale for
DSM-IV Borderline Personality Disorder. The National
Education Alliance for Borderline Personality Disorder
presented her with the Herb Pardes Senior Investigator Award
in 2005.
Widely published, Dr. Zanarini is a reviewer or editorial
board member of numerous scientific journals, including
Archive of General Psychiatry, American Journal of
Psychiatry, Journal of Personality Disorders, and Biological
Psychiatry. She is a member of the American Psychological
Association, the International Society for the Study of
Personality Disorders, the Association for Clinical
Psychosocial Research, and the Association for Psychological
Science. |
| Assessing and Managing the Risk of Suicide in Patients with
Borderline Personality Disorder |
Paul S. Links, MD, FRCP(C)
Arthur Sommer Rotenberg Chair of Suicide Studies, University
of Toronto
Research Scientist, Centre for Research on Inner City
Health,
St. Michael's Hospital, Toronto
Associate Member, University of Toronto, Faculty of
Medicine, Behavioural Sciences
Associate Member, Institute of Medical Science
Professor, University of Toronto, Faculty of Medicine,
Psychiatry
Deputy Chief of Psychiatry, St. Michael's Hospital
Professor Paul Links, of the Department of Psychiatry,
University of Toronto is the incumbent of the Arthur Sommer
Rotenberg Chair in Suicide Studies; the first academic Chair
in North America dedicated to suicide research. Dr. Links
has formed a team of researchers dedicated to the study of
suicide, one of the leading causes of death for people under
35 years of age.
Dr. Links is the Deputy Chief of Psychiatry of the St.
Michael’s Hospital’s Mental Health Service. In addition to
the Chair, he continues with his clinical work with
individuals at risk for suicide.
He has published over 75 articles in scientific journals and
two books. As a principal investigator he has received
research grants from many agencies including the Canadian
Institutes of Health Research, Health and Welfare Canada,
the Ontario Ministry of Health and the Ontario Mental Health
Foundation. Dr. Links is the President of the Canadian
Association for Suicide Prevention.
Dr. Links’ clinical experience and expertise developed from
working with both acutely suicidal and persistently suicidal
patients (those who face a life-and-death struggle on a
daily basis and are at high risk of taking their own lives). |
| Dialectical
Behavior Therapy |
JoAnn Heap, LMSW, ACSW
Director of Dialectical Behavior Therapy
University of Michigan Department of Psychiatry
and Washtenaw County Community Support and Treatment
Services |
| Psychodynamic
Psychotherapies for Borderline Conditions:
Transference-Focused Psychotherapy and Mentalization-Based
Psychotherapy |
Frank E. Yeomans, MD, PhD
Clinical Associate Professor of Psychiatry, Weill
Medical College, Cornell University
Director of Training, Personality Disorders Institute, New York
Pres Dr. Yeomans is Clinical Associate Professor of Psychiatry
at the Weill Medical College of Cornell University, Director
of Training at the Personality Disorders Institute of
Weill-Cornell, and Lecturer in Psychiatry at the Columbia
Center for Psychoanalysis. Other positions included Unit
Chief of the Psychodynamic Unit for Borderline Conditions at
the New York Hospital-Westchester Division. More recently,
Dr. Yeomans has become Director of the Personality Studies
Institute in Manhattan. He has participated in establishing
training programs for psychodynamic therapy of personality
disorders in numerous other sites in North America and
Europe.
He has authored and co-authored numerous articles and
several books on psychotherapy research and technique,
including, with Drs. Kernberg and Clarkin, A Primer on
Transference-Focused Psychotherapy for the Borderline
Patient, and Psychotherapy for Borderline Personality. |
|
Psychopharmacology: Its Effects and Limitations |
Kenneth R.
Silk, MD
Professor, Director, Personality Disorders Program
Department of Psychiatry,
University of Michigan Health System
Dr. Silk received his B.A. in Biology from Brandeis
University, his M.D. from Albert Einstein College of
Medicine. He did his psychiatry residency at Yale. He is
currently Professor, Department of Psychiatry, University of
Michigan Medical School. Since 1986, he has been Director,
Personality Disorders Program.
Dr. Silk has published close to 75 scientific articles and
book chapters. He edited Biological and Neurobehavioral
Studies of Borderline Personality Disorder (American
Psychiatric Press, 1994) and Biology of Personality
Disorders (1998) in the APA’s Annual Review of Psychiatry.
He co-authored with Allan Tasman and Michelle ba The
Doctor-Patient Relationship in Pharmacotherapy: Improving
Treatment Effectiveness (Guilford). He is currently in the
process of co-editing with Peter Tyrer, The Cambridge
University Press Textbook of Effective Treatments in
Psychiatry that hopefully will be published in the late
summer/early fall of 2007.
He is Secretary-Treasurer of the International Society for
the Study of Personality Disorders. He is a Past-President
and Treasurer of the Association for Research in Personality
Disorders. He is immediate Past President of the Michigan
Psychiatric Society and serves on the Annual Meeting
Scientific Program Committee for the American Psychiatric
Association.
Dr. Silk worked for 20 years on inpatient units. He became
Chief, Adult Services, at University of Michigan, in 1991
and Associate Chair in 1994. He held both positions until
January of 2006.
Dr. Silk currently is doing PET research, studying mu-opioid
receptor activation in patients with borderline personality
disorder in response to induced sadness (as a paradigm of
psychological pain) as well as in response to physical pain.
The findings in these studies will be compared to the
findings in depressed outpatients. Dr. Silk has received
funding from the Borderline Personality Disorders Research
Foundation and the NIMH for these projects.
Dr. Silk has, throughout his career, been an active
clinician and teacher. His primary interest has always been
the treatment and management of severely ill patients and
the problems that they present to clinicians in the clinical
arena. |
Family
Perspectives and Family Connections: Family and
Consumer Perspectives
|
Perry D. Hoffman, PhD
President, National Education Alliance for
Borderline Personality Disorder (NEA-BPD)
Perry D. Hoffman, Ph.D. is on the voluntary faculty
of the Mount Sinai School of Medicine. She is co-designer of
the 12-week education course for families, Family
Connections, which is available in many locations both in
the United States as well as other countries. Dr Hoffman has
several grants from the National Institute of Mental Health
(NIMH) with a focus on families who have a relative with
borderline personality disorder. She is also Co-Director of
the five-year NIMH-funded Family Perspectives on Borderline
Personality Conferences. Dr. Hoffman is a co editor, with
John G. Gunderson, MD, of the book Understanding and
Treating Borderline Personality Disorder: A Guide for
Professionals and Family Members, published by the American
Psychiatric Press. |
| |
|
|
|
|
|
|
| |
 |
|
|
|
|
|
|
|
|